CHRNA7 and atherosclerosis: To investigate the effects of alpha 7 nicotinic acetylcholine receptor (α7nAChR) stimulation on atherosclerosis in apolipoprotein E deficient (ApoE-/-) mice, mice were treated with α7nAChR agonist AZ6983 for 8 weeks.